T. Rowe Price Investment Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1K | Sell |
|
|||||
|
2025
Q2 | $10K | Sell |
|
|||||
|
2025
Q1 | $5.77M | Sell |
|
|||||
|
2024
Q4 | $8.96M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $31.5M | Buy |
|
|||||
|
2023
Q4 | $76.1M | Buy |
|
|||||
|
2023
Q3 | $61.9M | Buy |
|
|||||
|
2023
Q2 | $82.1M | Buy |
|
|||||
|
2023
Q1 | $62.8M | Sell |
|
|||||
|
2022
Q4 | $49.7M | Sell |
|
|||||
|
2022
Q3 | $44M | Buy |
|